BSE Live
Jan 05, 16:01Prev. Close
30.40
Open Price
31.92
Bid Price (Qty.)
31.92 (182119)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 05, 16:09Prev. Close
30.32
Open Price
31.83
Bid Price (Qty.)
31.83 (131189)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Mangalam Drugs & Organics (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 317.58 | 367.35 | 370.20 | 447.56 | 410.31 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 30.17 | |
| Revenue From Operations [Net] | 317.58 | 367.35 | 370.20 | 447.56 | 380.14 | |
| Total Operating Revenues | 318.23 | 368.59 | 372.25 | 451.07 | 380.14 | |
| Other Income | 0.50 | 0.10 | 0.44 | 0.09 | 4.72 | |
| Total Revenue | 318.73 | 368.69 | 372.69 | 451.16 | 384.86 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 170.56 | 224.76 | 277.45 | 339.08 | 256.02 | |
| Purchase Of Stock-In Trade | 18.33 | 10.65 | 15.36 | 1.31 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -21.52 | 9.10 | -42.16 | -33.75 | -4.23 | |
| Employee Benefit Expenses | 40.59 | 39.07 | 34.61 | 37.25 | 29.88 | |
| Finance Costs | 14.93 | 13.92 | 12.75 | 11.16 | 9.33 | |
| Depreciation And Amortisation Expenses | 16.38 | 14.63 | 10.99 | 10.25 | 9.18 | |
| Other Expenses | 74.47 | 67.62 | 61.48 | 58.12 | 45.18 | |
| Total Expenses | 313.74 | 379.75 | 370.47 | 423.42 | 345.34 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 4.99 | -11.06 | 2.21 | 27.73 | 39.52 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 4.99 | -11.06 | 2.21 | 27.73 | 39.52 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.91 | 0.00 | 0.39 | 8.76 | 9.27 | |
| Less: MAT Credit Entitlement | 0.83 | 0.00 | 0.37 | 0.00 | 0.00 | |
| Deferred Tax | -2.02 | -2.20 | 0.97 | -0.73 | 2.28 | |
| Tax For Earlier Years | 0.00 | 0.19 | -0.05 | 0.05 | 0.00 | |
| Total Tax Expenses | -1.93 | -2.01 | 0.94 | 8.08 | 11.55 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 6.92 | -9.05 | 1.27 | 19.66 | 27.97 | |
| Profit/Loss From Continuing Operations | 6.92 | -9.05 | 1.27 | 19.66 | 27.97 | |
| Profit/Loss For The Period | 6.92 | -9.05 | 1.27 | 19.66 | 27.97 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 4.37 | -5.72 | 0.80 | 12.42 | 17.67 | |
| Diluted EPS (Rs.) | 4.37 | -5.72 | 0.80 | 12.42 | 17.67 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
25.11.2025
Mangalam Drugs Consolidated September 2025 Net Sales at Rs 49.54 crore, down 38.03% Y-o-Y
24.11.2025
Mangalam Drugs Standalone September 2025 Net Sales at Rs 49.54 crore, down 38.03% Y-o-Y
22.08.2025
Mangalam Drugs Standalone June 2025 Net Sales at Rs 57.35 crore, down 25.07% Y-o-Y
19.05.2025
Mangalam Drugs Standalone March 2025 Net Sales at Rs 73.04 crore, down 28.56% Y-o-Y